Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 180 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

 		Relapsing Forms of Multiple Sclerosis

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

 		Prostate Cancer Phase4

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

 		B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL) Phase1

Study of Out of Specification for Tisagenlecleucel

 		B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma Phase3

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

 		Follicular Lymphoma (FL) Phase3

Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

 		Chronic Myelogenous Leukemia - Chronic Phase Phase2

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

 		Uncomplicated Plasmodium Falciparum Malaria Phase2

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

 		Hypertension Phase3

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

 		Heart Failure Phase2

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

 		Primary Prevention of Atherosclerotic Cardiovascular Disease Phase3